Skip to content
  • Saturday, 15 August 2026
  • 1:51 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough in Van der Waals Semiconductors: XPANCEO and Nobel Laureate Unveil Light-Driven Optical Fabrication in Arsenic Trisulfide
Advanced Materials Science

Breakthrough in Van der Waals Semiconductors: XPANCEO and Nobel Laureate Unveil Light-Driven Optical Fabrication in Arsenic Trisulfide

Nila Kartika Wati May 16, 2026 0

Researchers at the XPANCEO Emerging Technologies Research Center, in a strategic collaboration with Nobel Laureate Professor Konstantin Novoselov of the…

Read More
Advanced Materials Science

XPANCEO and Nobel Laureate Konstantin Novoselov Unveil Breakthrough in Light-Driven Nanophotonics Using Van Der Waals Semiconductors

Nila Kartika Wati Apr 29, 2026 0

The field of photonics has reached a significant milestone as researchers from the XPANCEO Emerging Technologies Research Center, in a…

Read More
CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and UgandaUnlocking the Brains Role in Diabetes Management New Study Reveals Metformin Acts Through Hypothalamic Pathways to Regulate Blood SugarCitius Oncology Secures Up to $36.5 Million in Debt and Equity Financing to Fuel Lymphir CommercializationCornell University Engineers Develop Microscale Wireless Neural Implant Capable of Long-Term Brain Activity Monitoring and Data Transmission
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ